U.S. farm income could drop 6.5 percent in 2012
The biggest crop acreage in a generation and increasing costs for fuel, pesticides and feed will trim the record profits seen in 2011 to $91.7 billion, according to the USDA.
Bloomberg News
Articles
Frontier trims Milwaukee flights as Republic seeks buyer
Frontier Airlines will cut daily departures from Milwaukee by 44 percent to drop unprofitable flights as Indianapolis-based parent Republic Airways Holdings Inc. prepares to sell or spin off the carrier.
Farmers plan biggest crops since 1984, led by corn
U.S. farmers will plant the most acres in a generation this year, led by the biggest corn crop since World War II, taking advantage of the highest agricultural prices in at least four decades.
Republic says potential buyers have surfaced for Frontier Air
Republic Airways Holdings Inc. has heard from potential buyers for Frontier Airlines and is close to naming an adviser on whether the unit will be sold or spun off to shareholders, CEO Bryan Bedford said.
Super Bowl just misses major-market TV-rating record
The New York Giants’ 21-17 win over the New England Patriots in Sunday night’s Super Bowl narrowly missed drawing the highest major-market television rating in National Football League history.
Lilly freezes salaries as generics erode Zyprexa sales
Eli Lilly and Co. will freeze salaries for most employees worldwide this year, as sales of its best-selling drug declined faster than expected after losing patent protection.
Super Bowl average ticket price slips to $3,664
The average ticket price for the Super Bowl rematch between the New York Giants and New England Patriots in Indianapolis has fallen 15 percent in the last six days, according to sellers on the secondary market.
Lilly eying deal with Turkish drug company
Eli Lilly and Co. is among about a half-dozen companies interested in buying a stake in Mustafa Nevzat Ilac Sanayii AS in a deal that may value the Turkish drugmaker at $1 billion, sources say.
Symmetry Ex-CEO Moore to return $450,000 in clawback suit
Symmetry Medical Inc.’s former CEO will return $450,000 in pay and stock proceeds to resolve U.S. Securities and Exchange Commission claims that he profited from accounting fraud by a United Kingdom unit.
Average price of Super Bowl ticket slides on secondary market
The average price for a ticket to the Feb. 5 game at Lucas Oil Stadium in Indianapolis fell to $3,982 on Monday, down from $4,311 since Jan. 27.
Lilly’s ex-partner wins FDA approval for diabetes drug
Amylin Pharmaceuticals Inc. and Alkermes Plc have gained U.S. clearance for Bydureon, a once-weekly diabetes shot. Eli Lilly and Co. co-developed the drug, but ended its partnership with Amylin last year.
EnerDel parent seeks Chapter 11 bankruptcy protection
Ener1 Inc., which received a $118 million U.S. Energy Department grant to make electric-car batteries, filed for Chapter 11 bankruptcy protection Thursday after defaulting on bond debt amid heavy competition from Asia.
Giants-Patriots Super Bowl ticket sells for $11,883
The average price for Super Bowl tickets sold on NFL Ticket Exchange so far is $4,183, slightly more than last year’s championship game between the Green Bay Packers and Pittsburgh Steelers, when sales averaged $4,140.
French breast-implant recall could sway U.S. device debate
U.S. medical device makers have spent the last year urging government officials to approve high-risk products faster, like their European counterparts. A scandal over leaking breast implants made in France, however, may make the argument more difficult.
NCAA delays decision on stipend for scholarship athletes
The National Collegiate Athletic Association will wait to decide on whether scholarship athletes at college sports’ top division will be eligible for as much as $2,000 a year to pay for food, transportation and other incidental expenses.
Lilly’s Zyprexa pact with health providers wins approval
Eli Lilly and Co. has won approval of a $4.5 million settlement with five union health funds and an insurer that alleged improper marketing of the company's best-selling medication, Zyprexa, raised their costs.
Simon cashes out of venture that owns 46 Italian centers
The Indianapolis developer's sale of its 49-percent stake further reduces the company's presence in Europe.
Lilly challenging Biogen patent in London lawsuit
Eli Lilly and Co. has sued Biogen Idec Inc. in a London court to revoke a European patent on a potential treatment for immune-system diseases.
Lilly’s 2012 earnings forecast misses analyst estimates
Indianapolis-based Eli Lilly and Co. provided a 2012 earnings forecast Thursday morning that missed analyst estimates by a wide margin, sending shares down.
Lugar: Tea Party could cost Senate GOP majority
Tea Party supporters that helped the Republicans win a U.S. House majority last year also prevented the party from taking control of the Senate and could do it again in 2012, Senator Richard Lugar said.